Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?
Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.
Eli Lilly's Diabetes Drug May Halt Heart Disease
Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.